{
    "id": 28676,
    "fullName": "AFP over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "AFP over exp indicates an over expression of the Afp protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 174,
        "geneSymbol": "AFP",
        "terms": [
            "AFP",
            "AFPD",
            "FETA",
            "HPAFP"
        ]
    },
    "variant": "over exp",
    "createDate": "09/21/2018",
    "updateDate": "10/08/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15027,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a bladder urothelial carcinoma patient with high serum levels of Afp (alpha-fetoprotein) had a complete response Keytruda (pembrolizumab) (PMID: 30208947).",
            "molecularProfile": {
                "id": 30561,
                "profileName": "AFP over exp"
            },
            "therapy": {
                "id": 1447,
                "therapyName": "Pembrolizumab",
                "synonyms": null
            },
            "indication": {
                "id": 4006,
                "name": "bladder urothelial carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 12307,
                    "pubMedId": 30208947,
                    "title": "Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an\u00a0escape lesion mimic.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30208947"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30561,
            "profileName": "AFP over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}